Characterization of a receptor mediating adiponectin functions on bone
介导骨脂联素功能的受体的表征
基本信息
- 批准号:9118629
- 负责人:
- 金额:$ 44.01万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:2015
- 资助国家:美国
- 起止时间:2015-09-15 至 2016-08-31
- 项目状态:已结题
- 来源:
- 关键词:AddressAdipocytesAffectAge-Related Bone LossAnimal FeedAnimalsAntibodiesApoptosisBiochemicalBiologicalBiological AssayBiologyBlood - brain barrier anatomyBone DiseasesBone Formation InhibitionBone remodelingBrainCellsCeramidesCollagenCollagen ReceptorsCommunicationDDR1 geneDataDietDiseaseEnergy MetabolismEvolutionFatty acid glycerol estersGene DeletionGenerationsGenesGoalsH-CadherinHealthHepatocyteHormone ReceptorHormone useHormonesHumanHuman GeneticsInsulin ReceptorKineticsLeadLeptinMediatingMolecularMusMyoblastsNerveNeuronsOrganOsteoblastsOsteocalcinOsteogenesisOsteoporosisPhenotypePhosphorylationPhysiological ProcessesPhysiologyProtein Tyrosine PhosphataseProto-Oncogene Proteins c-aktReceptor Protein-Tyrosine KinasesReceptor SignalingRecruitment ActivityRegulationRelative (related person)Signal PathwaySignal TransductionSympathetic Nervous SystemTestingTherapeuticTimeTranslatingUrsidae FamilyVisionWhole Organismadiponectinage relatedbasebonebone massdesigndiscoidin domain receptor 2discoidin receptorfeedingin vivoinhibiting antibodyinterestknock-downlocus ceruleus structuremouse genomemouse modelnovelpreventreceptorskeletaltranscription factor
项目摘要
DESCRIPTION (provided by applicant): We have been interested in recent years in the biology of the most abundant adipokine, adiponectin. In addressing what could be the functions(s) of adiponectin in animals fed a normal diet we considered the fact that adiponectin appears during evolution with bone and is regulated by the bone-derived hormone osteocalcin. We then asked whether adiponectin was regulating bone mass. Our results obtained in vivo showed that 1) adiponectin inhibits bone formation by acting directly on osteoblasts while it favors bone formation by inhibiting the sympathetic nerves through its signaling in the brain; 2) none of the known receptors for adiponectin seem to mediate any of these two functions and adiponectin does not recruit AMPK and does not regulate ceramide activity in osteoblasts; 3) the signaling pathway triggered by adiponectin in osteoblasts suggested that the receptor for this hormone in osteoblasts is a receptor tyrosine kinase. Further analysis presented in this application strongly suggest, based on molecular and biochemical grounds, that the receptor for adiponectin in osteoblasts and possibly in neurons of the locus coeruleus may be the discoidin receptor 2 (DDR2), a RTK with a slow kinetic of phosphorylation. Based on preliminary findings presented in this application we now propose to test this hypothesis in vivo. The specific aims of this application are: To demonstrate that DDR2 mediates adiponectin signaling in osteoblasts. To demonstrate that in vivo FoxO1 lies downstream of DDR2-dependent signaling in osteoblasts. To determine in vivo the biological significance of the interactions occurring between DDR2, AdipoR1 and T-cadherin. To demonstrate in vivo that DDR2 and/or DDR1 mediates adiponectin signaling in neurons of the locus coeruleus.
描述(由适用提供):近年来,我们对最丰富的脂肪因子脂联素的生物学感兴趣。在解决喂养正常饮食的动物中脂联素的功能时,我们认为脂联素在骨骼进化过程中出现在骨骼进化过程中,并且受骨衍生的霍斯烯骨钙钙蛋白的调节。然后,我们询问脂联素是否控制骨骼质量。我们在体内获得的结果表明,1)脂联素通过直接作用于成骨细胞来抑制骨形成,同时通过通过大脑中的信号抑制交感神经系统来促进骨形成; 2)脂联素的已知受体似乎都没有介导这两个功能中的任何一种,脂联素不募集AMPK,也不调节成骨细胞中的神经酰胺活性。 3)脂联素在成骨细胞中触发的信号传导途径表明,在成骨细胞中该赛马的受体是一种受体酪氨酸激酶。在该应用中提出的进一步分析强烈地表明,基于分子和生化基础,成骨细胞中脂联素的受体以及在层层基因座的神经元中可能的受体可能是盘状受体2(ddr2),一种rtk,rtk的磷酸化速度缓慢。基于本应用程序中提出的初步发现,我们现在建议在体内检验该假设。该应用的具体目的是:证明DDR2介导成骨细胞中的脂联素信号传导。为了证明体内FOXO1位于成骨细胞中DDR2依赖性信号的下游。为了确定体内DDR2,adipor1和t-钙粘着蛋白之间发生相互作用的生物学意义。在体内证明DDR2和/或DDR1介导位点神经元中的脂联素信号传导。
项目成果
期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
数据更新时间:{{ journalArticles.updateTime }}
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
Gerard Karsenty其他文献
Gerard Karsenty的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('Gerard Karsenty', 18)}}的其他基金
A Neuronal Basis for the Osteocalcin Regulation of Bone Mass
骨钙素调节骨量的神经元基础
- 批准号:
9764336 - 财政年份:2018
- 资助金额:
$ 44.01万 - 项目类别:
A Neuronal Basis for the Osteocalcin Regulation of Bone Mass
骨钙素调节骨量的神经元基础
- 批准号:
9979842 - 财政年份:2018
- 资助金额:
$ 44.01万 - 项目类别:
A Neuronal Basis for the Osteocalcin Regulation of Bone Mass
骨钙素调节骨量的神经元基础
- 批准号:
10210255 - 财政年份:2018
- 资助金额:
$ 44.01万 - 项目类别:
A Neuronal Basis for the Osteocalcin Regulation of Bone Mass
骨钙素调节骨量的神经元基础
- 批准号:
10455018 - 财政年份:2018
- 资助金额:
$ 44.01万 - 项目类别:
Serotonin as a Regulator of Bone Mass Accrual: Basic and Clinical
血清素作为骨量增长的调节剂:基础和临床
- 批准号:
8302302 - 财政年份:2010
- 资助金额:
$ 44.01万 - 项目类别:
Regulation of osteocalcin secretion and its therapeutic implication
骨钙素分泌的调节及其治疗意义
- 批准号:
10024563 - 财政年份:2010
- 资助金额:
$ 44.01万 - 项目类别:
相似国自然基金
多组学研究STAT3调控CKMT2和CD36-FABP4影响脂肪细胞参与乳腺癌细胞磷酸肌酸合成的耐药代谢重编程
- 批准号:82360604
- 批准年份:2023
- 资助金额:32 万元
- 项目类别:地区科学基金项目
FTL+ALB+脂肪干细胞与CD36+EBF2-内皮细胞通过交互作用影响脂肪组织衰老的机制研究
- 批准号:82370884
- 批准年份:2023
- 资助金额:49 万元
- 项目类别:面上项目
微小微单胞菌调控巨噬细胞脂肪酸代谢酶m6A修饰影响结直肠癌免疫治疗的机制研究
- 批准号:82372732
- 批准年份:2023
- 资助金额:49 万元
- 项目类别:面上项目
m6A甲基化双向调控Rab7/Bcl2l1介导自噬影响糖尿病性骨质疏松症脂肪干细胞骨向分化的机制研究
- 批准号:82370938
- 批准年份:2023
- 资助金额:48 万元
- 项目类别:面上项目
CCL5/CCR5通路调控猪皮下脂肪细胞向肌肉迁移及其对肌内脂肪影响的机制研究
- 批准号:32372853
- 批准年份:2023
- 资助金额:50 万元
- 项目类别:面上项目
相似海外基金
Impact of Exposure to Perfluoroalkyl Substances on Weight Loss: A Pilot Study of Hispanic Children with Overweight/Obesity Participating in a Community-based Weight Loss Intervention Program
接触全氟烷基物质对减肥的影响:对参加社区减肥干预计划的超重/肥胖西班牙裔儿童的初步研究
- 批准号:
10724050 - 财政年份:2023
- 资助金额:
$ 44.01万 - 项目类别:
Novel therapies for obesity- or diabetes-related lymphatic dysfunction
肥胖或糖尿病相关淋巴功能障碍的新疗法
- 批准号:
10602589 - 财政年份:2023
- 资助金额:
$ 44.01万 - 项目类别:
Deciphering the lipid composition of primary cilia in human metabolic disease
破译人类代谢疾病中初级纤毛的脂质成分
- 批准号:
10696465 - 财政年份:2023
- 资助金额:
$ 44.01万 - 项目类别: